SCIENCE BRIEFING
Times Staff and Wire Reports
A new formula that includes gene testing has proved much better at setting the ideal dose for the blood thinner warfarin than what doctors do now: Give a standard amount and adjust it by trial and error.
The formula was tested in a large international study, published Thursday in the New England Journal of Medicine.
A new experiment will soon test the gene study’s results in a more rigorous way. Most patients will probably have to wait at least a few years before genetic testing becomes a common factor in warfarin dosing.
